NEW YORK (GenomeWeb News) - The Genetic Association Information Network, a public and private partnership, will use Affymetrix's Genome-Wide Human SNP Array 6.0 in genomic studies of schizophrenia and bipolar disorder, Affy said today.
GAIN is run by the Foundation for the National Institutes of Health, the National Institutes of Health, and Pfizer Global Research and Development.
Affy said GAIN scientists will use the Human SNP 6.0 to analyze eight thousand samples from various ethnicities.
The company also said the GAIN program will provide information it collects to researchers worldwide through the National Center for Biotechnology Information’s database of Genotype and Phenotype, or dbGaP.
Financial terms of the agreement were not released.